These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2410812)

  • 1. Some indices of the catecholamine and indoleamine metabolism in groups of patients with paranoid and simple forms of schizophrenia.
    Gamaleya NB
    Neurosci Behav Physiol; 1985; 15(2):103-10. PubMed ID: 2410812
    [No Abstract]   [Full Text] [Related]  

  • 2. [Catecholamine and indoleamine metabolism in groups of patients with paranoid and simple forms of schizophrenia].
    Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(5):700-8. PubMed ID: 6168149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the levels of adrenergic and serotoninergic indices in patients with depressive states].
    Misionzhnik EIu; Vertogradova OP; Krasnov VN; Salenko BB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(4):543-51. PubMed ID: 6168150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relation between the urinary levels of biogenic amines and their metabolites in depression before and after treatment].
    Puzyński S; Bidziński A; Hauptmann M; Rode A; Załuska M
    Psychiatr Pol; 1980; 14(5):457-63. PubMed ID: 6162167
    [No Abstract]   [Full Text] [Related]  

  • 5. [Differences in serotonin and dopamine metabolism in psychopathy and sluggish schizophrenia].
    Zabrodin GD; Turova ZG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(11):1673-7. PubMed ID: 1015096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-lysergic acid diethylamide (LSD)--effect on biogenic amines excretion in man.
    Messiha FS; Grof S
    Biochem Pharmacol; 1973 Sep; 22(18):2352-4. PubMed ID: 4733686
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain monoamine changes in chronic paranoid schizophrenia and their possible relation to increased dopamine receptor sensitivity.
    Farley IJ; Shannak KS; Hornykiewicz O
    Adv Biochem Psychopharmacol; 1980; 21():427-33. PubMed ID: 6155058
    [No Abstract]   [Full Text] [Related]  

  • 8. [Excretion of catecholamines and tryptophan derivatives in schizophrenia].
    Mileikovskii IuA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(5):710-4. PubMed ID: 132832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiologic mechanisms of depressive states of endogenous or exogenous origin].
    Biriukovich PV; Sinitskiĭ VN; Usherenko LS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(8):1208-17. PubMed ID: 696111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cannabis sativa administered by smoking on biogenic amine excretion in man.
    Messiha FS; Soskin RA
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):325-8. PubMed ID: 4734006
    [No Abstract]   [Full Text] [Related]  

  • 11. A study of biogenic amine metabolites in the cerebrospinal fluid and urine of monkeys with chlorpromazine-induced dyskinesia.
    Messiha FS
    J Neurol Sci; 1974 Jan; 21(1):39-46. PubMed ID: 4216622
    [No Abstract]   [Full Text] [Related]  

  • 12. Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia.
    Oades RD; Klimke A; Henning U; Rao ML
    Hum Psychopharmacol; 2002 Jan; 17(1):15-27. PubMed ID: 12404703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Various features of dopamine metabolism in schizophrenia].
    Anokhina IP; Kogan BM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(9):1343-7. PubMed ID: 6798791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Various indices of biogenic monoamine metabolism in schizophrenic patients during treatment with atropine comas].
    Reminiak VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(8):85-92. PubMed ID: 6182710
    [No Abstract]   [Full Text] [Related]  

  • 15. Imipramine-mediated effects on levodopa metabolism in man.
    Messiha FS; Morgan JP
    Biochem Pharmacol; 1974 May; 23(10):1503-7. PubMed ID: 4847533
    [No Abstract]   [Full Text] [Related]  

  • 16. High-performance liquid chromatography of biogenic amines and metabolites in brain, cerebrospinal fluid, urine and plasma.
    Seegal RF; Brosch KO; Bush B
    J Chromatogr; 1986 Apr; 377():131-44. PubMed ID: 2423546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of dopamine metabolite correlate with mismatch negativity in patients with schizophrenia.
    Shiga T; Horikoshi S; Kanno K; Kanno-Nozaki K; Hikita M; Itagaki S; Miura I; Yabe H
    Psychiatry Clin Neurosci; 2020 May; 74(5):289-293. PubMed ID: 31994282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional distribution of monoamines and their metabolites in the human brain.
    Mackay AV; Yates CM; Wright A; Hamilton P; Davies P
    J Neurochem; 1978 Apr; 30(4):841-8. PubMed ID: 650225
    [No Abstract]   [Full Text] [Related]  

  • 19. [The relationship of the metabolism of biogenic amines to affective pathology in chronic alcoholism].
    Skugarevskaia EI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):896-9. PubMed ID: 5364242
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biogenic amine levels in patients with traumatic epilepsy].
    Boldyrev AI; Lando LI; Balashova LN; Misionzhnik EIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(3):388-93. PubMed ID: 804223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.